Clinical Research Directory
Browse clinical research sites, groups, and studies.
Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
Sponsor: Zhongshan People's Hospital, Guangdong, China
Summary
Based on the preliminary retrospective validation of the efficacy of five HCC screening strategies(including conventional AFP combined with ultrasound-based general screening strategy, REACH-B, AGED, aMAPand aMAP 3.0 risk score) in Xiaolan Town, a head-to-head comparison for HCC screening is conducted in Zhongshan City, Guangdong Province. The study is a prospective, single-center, head-to-head trial aiming to enroll 4,500 HBsAg-positive individuals. It adopts a two-phase design of "HBV screening first, followed by HCC surveillance":Phase I: Recruitment of age-eligible populations at study sites for HBsAg screening to establish a high-risk cohort positive for hepatitis B surface antigen.Phase II: Implementation of uniform HCC surveillance (AFP combined with liver ultrasound every six months) for HBsAg-positive individuals, with concurrent application of different risk stratification models to evaluate risk levels and screening efficacy for each participant during follow-up.Furthurmore, based on baseline biological information and follow-up data, the study also aims to explore the development of a more effective risk prediction model for HCC.
Key Details
Gender
All
Age Range
35 Years - Any
Study Type
OBSERVATIONAL
Enrollment
4500
Start Date
2025-03-01
Completion Date
2028-12-31
Last Updated
2025-06-08
Healthy Volunteers
Yes
Conditions
Interventions
Quantitative HBeAg Testing
Quantitative HBeAg Testing in Population-Based Primary Screening
Measurement Indicators Required for Risk Scoring in HCC Screening Strategies
REACH-B: Age, Sex, HBeAg status, ALT levels, and HBV DNA load; AGED: Age, Sex, HBeAg status, HBV DNA load; aMAP: Age, Sex, Albumin, Total Bilirubin, Platelet Count; aMAP 3.0: Age, Sex, Albumin, Total Bilirubin, Platelet Count, AFP and PIVKA-II.
Follow-Up Monitoring Parameters
AFP, Liver Ultrasound
Locations (1)
Zhongshan People's Hospital
Zhongshan, Guangdong, China